Ege University Hospital Implants Turkey's 1st Total Artificial Heart
Total Artificial Heart Only Suitable Device for 47-Year-Old Patient with Less Than 2 Weeks to Live
TUCSON, Ariz. – Oct. 19, 2010 – On Sept. 30, Ege University Hospital in Izmir performed Turkey's first implant of the SynCardia temporary Total Artificial Heart. The surgery was led by Prof. Dr. Mustafa Ozbaran, head of the Transplant and Assist Device Program, and proctored by experienced Total Artificial Heart surgeon Dr. Latif Arusoglu.
"We have extensive experience with BiVADs, but for such a sick patient, the Total Artificial Heart was the only suitable device," said Prof. Dr. Ozbaran. "The Total Artificial Heart provides a high volume of blood flow to help recover the vital organs. There is no need for inotropes and you do not have to worry about arrhythmia."
The 47-year-old patient, who had his mitral and atrial heart valves replaced 21 years ago, was suffering from dilated cardiomyopathy. He has been waiting for a heart transplant for two years and was moved up to emergency status two and half months ago. Prior to implant, the patient had spent three weeks in the ICU and was inotrope dependent and suffering from severe arrhythmia. Doctors expected the patient's survival was less than 15 days without the Total Artificial Heart.
Ege University is one of the biggest and oldest universities in Turkey. The heart transplant program, started in 1998, has become the most active program in the country. Each year, Ege University performs approximately 1,100 open heart surgeries. In Turkey, the average wait time for a donor heart transplant is 18 to 24 months. Ege University is the first transplant hospital in Turkey and the 33rd in the world to become a SynCardia Certified Center.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463